Now Even the “Good” Tests Are Coming Under Fire by Glenn S. Demby | May 26, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, FDA-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
SARS-CoV-2 Antigen Testing Is Here but Is It Really a ‘Game Changer’ by Glenn S. Demby | May 25, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
Serology Testing Critical to COVID-19 Survival & Post-Crisis Transition by Glenn S. Demby | Apr 19, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, FDA-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
Are Rapid Immunodiagnostic Tests for COVID-19 Ready for Prime Time? by Glenn S. Demby | Apr 19, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, FDA-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
VITAL Act Would Eliminate FDA Regulation of New Tests During Health Emergencies by Glenn S. Demby | Apr 13, 2020 | Articles, CDC-nir, CLIA-nir, CMS-nir, Essential, FDA-nir, National Lab Reporter... This content is for Paid Members only.RegisterAlready a member? Log in here